Cargando…
Nano-BTA: A New Strategy for Intravesical Delivery of Botulinum Toxin A
Botulinum neurotoxin subtype A (BoNT-A) has been part of the urology treatment arsenal since it was first used in the treatment of detrusor-sphincter dyssynergia more than 30 years ago. BoNT-A has been recommended as an effective treatment for neurogenic detrusor overactivity and overactive bladder....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Continence Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260331/ https://www.ncbi.nlm.nih.gov/pubmed/35793987 http://dx.doi.org/10.5213/inj.2142124.062 |